IL-33 is a chemoattractant for human Th2 cells

被引:274
作者
Komai-Koma, Mousa
Xu, Damo
Li, Yubin
McKenzie, Andrew N. J.
McInnes, Iain B.
Liew, Foo Y.
机构
[1] Univ Glasgow, Glasgow Biomed Res Ctr, Div Immunol Infect & Inflammat, Glasgow G12 8TA, Lanark, Scotland
[2] MRC, Mol Biol Lab, Cambridge CB2 2QH, England
基金
英国医学研究理事会;
关键词
cell migration; IL-33; Th2; cells;
D O I
10.1002/eji.200737547
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
IL-33 is a novel cytokine of the IL-1 family and mediates its biological effect via the receptor ST2, which is selectively expressed on Th2 cells but not Th1 cells. IL-33 drives production of Th2-associated cytokines including IL-5 and IL-13 and thereby promotes defense and pathology in mucosal organs. Cell locomotion is crucial to the induction of an effective immune response. We report here the chemoattraction of Th2 cells by IL-33. Recombinant IL-33 increased the proportion of human Th2 cells, but not Th1 cells, in polarized morphology in vitro and stimulated their subsequent invasion into collagen gels in an IL-33 concentration-dependent manner. Injection of recombinant IL-33 into the footpad of ST2(-/-) mice which had been adoptively transferred with polarized Th2 cells, led to local accumulation of the transferred Th2 cells. These data therefore demonstrate that IL-33 is a selective Th2 chemoattractant associated with the pro-inflammatory property of this novel cytokine.
引用
收藏
页码:2779 / 2786
页数:8
相关论文
共 23 条
  • [1] Increased levels of soluble ST2 protein and IgG1 production in patients with sepsis and trauma
    Brunner, M
    Krenn, C
    Roth, G
    Moser, B
    Dworschak, M
    Jensen-Jarolim, E
    Spittler, A
    Sautner, T
    Bonaros, N
    Wolner, E
    Boltz-Nitulescu, G
    Ankersmit, HJ
    [J]. INTENSIVE CARE MEDICINE, 2004, 30 (07) : 1468 - 1473
  • [2] Crucial role of the interleukin 1 receptor family member T1/ST2 in T helper cell type 2-mediated lung mucosal immune responses
    Coyle, AJ
    Lloyd, C
    Tian, J
    Nguyen, T
    Erikkson, C
    Wang, L
    Ottoson, P
    Persson, P
    Delaney, T
    Lehar, S
    Lin, S
    Poisson, L
    Meisel, C
    Kamradt, T
    Bjerke, T
    Levinson, D
    Gutierrez-Ramos, JC
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (07) : 895 - 902
  • [3] Chemoattraction of human T cells by IL-18
    Komai-Koma, M
    Gracie, JA
    Wei, XQ
    Xu, DM
    Thomson, N
    McInnes, IB
    Liew, FY
    [J]. JOURNAL OF IMMUNOLOGY, 2003, 170 (02) : 1084 - 1090
  • [4] KOMAIKOMA M, 1995, J IMMUNOL, V155, P1110
  • [5] Kropf P, 2002, EUR J IMMUNOL, V32, P2450, DOI 10.1002/1521-4141(200209)32:9&lt
  • [6] 2450::AID-IMMU2450&gt
  • [7] 3.0.CO
  • [8] 2-O
  • [9] A novel therapy of murine collagen-induced arthritis with soluble T1/ST2
    Leung, BP
    Xu, D
    Culshaw, S
    McInnes, LB
    Liew, FY
    [J]. JOURNAL OF IMMUNOLOGY, 2004, 173 (01) : 145 - 150
  • [10] T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function
    Löhning, M
    Stroehmann, A
    Coyle, AJ
    Grogan, JL
    Lin, S
    Gutierrez-Ramos, JC
    Levinson, D
    Radbruch, A
    Kamradt, T
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (12) : 6930 - 6935